Searched for
MERCK PHARMACEUTICAL RESTRUCTURING
MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
For moderate risk-takers with medium-term perspective: 5 mid-cap stocks from different sectors with the right financial matrixDespite the recent correction phase – though largely limited to select large-caps – we are still in a market where companies near bankruptc...
Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...
Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...
Stocks in focus on April 06, 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
Sensex rallies over 100 points, Nifty tests 8600 levels; ten stocks in focus in Monday's tradeThe S&P BSE Sensex rallied as much as 124 points in trade on Monday, following positive trend seen in other Asian markets.
- Now, Indian pharma companies like Jubilant Group, TCG Life Sciences and Piramal Life Sciences venture to share new drug R&D risks
Indian firms need handholding, but there have been times when they were left on their own after being assigned a project.
- HCL bags $500-mn IT outsourcing deal from Merck
HCL will provide BPO services, remote infrastructure management and enterprise application development for Merck. Latest buzz in IT industr...
J&J shows door to 80 execs; most jobs cut at mid-management levelJohnson & Johnson has laid off up to 80 mid-to-senior-level execs.
- Wockhardt puts marketing division Merind on block
After selling a slew of business divisions, Mumbai-based pharma company Wockhardt is learnt to have put its marketing division of pharmaceu...
- GlaxoSmithKline to axe 1,000 sales jobs in US
The world's No 2 drugmaker by revenue also will switch from having dual US headquarters to just North Carolina. Shrinking job mkt: The next...
- Kopran on the block
The Mumbai-based Kopran is on the block. The promoters and Clearwater Capital Partners of Cyprus, who together hold 44% equity, are believe...
- Novartis to cut 2,500 jobs worldwide by 2010
Novartis AG will cut 2,500 jobs worldwide by 2010 in an attempt to save $1.6 bn, the drugmaker said in becoming the latest major pharmaceut...
- Bristol-Myers to shut half of its plants in 3 years
Apart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...
- Merck queers pitch for Glenmark’s diabetes plan
In a potential blow to Indian drug maker Glenmark Pharmaceuticals, its outlicensing partner, Merck KGaA, has said it will stop its diabetes...
- India's on Merck's outsourcing radar
Global drug giant Merck plans to outsource a major part of its manufacturing process to the developing world and India may get a large chun...